Cardiff Oncology, Inc. financial statements
Cardiff Oncology, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 593K | 10-K |
| Net income | −USD 45.85M | 10-K |
| Cash and equivalents | USD 17.47M | 10-Q |
| Total debt | USD 832K | EODHD |
Cardiff Oncology, Inc. financials on 6ix · Cardiff Oncology, Inc. on 6ix